Discontinued — last reported Q4 '25
Thermo Fisher Scientific Finance Lease Liabilities (Total) remained flat by 0.0% to $213.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $200.00M to $213.00M. Over 5 years (FY 2020 to FY 2025), Finance Lease Liabilities (Total) shows an upward trend with a 98.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates a preference for financing asset acquisitions through leasing rather than cash or traditional loans, impacting long-term interest expense.
The aggregate amount of all current and non-current obligations related to finance leases, representing the total debt-e...
Investors use this to adjust debt metrics to ensure comparability between firms that buy assets and those that use finance leases.
finance_lease_liabilities_total| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.00M | $200.00M | $195.00M | $200.00M | $219.00M | $210.00M | $206.00M | $202.00M | $200.00M | $190.00M | $215.00M | $207.00M | $200.00M | $202.00M | $200.00M | $196.00M | $196.00M | $213.00M | $213.00M |
| QoQ Change | — | +83.5% | -2.5% | +2.6% | +9.5% | -4.1% | -1.9% | -1.9% | -1.0% | -5.0% | +13.2% | -3.7% | -3.4% | +1.0% | -1.0% | -2.0% | +0.0% | +8.7% | +0.0% |
| YoY Change | — | — | — | — | +100.9% | +5.0% | +5.6% | +1.0% | -8.7% | -9.5% | +4.4% | +2.5% | +0.0% | +6.3% | -7.0% | -5.3% | -2.0% | +5.4% | +6.5% |